Interní Med. 2008; 10(5): 233-239

Celiac disease - what shoUld an ambulant internist know

MUDr. Lucie Prokopová
III. interní klinika gastroenterologická, FN Brno-Bohunice

Celiac disease (celiac sprue gluten sensitive entheropathy, nontropic sprue) is the life long hereditary autoimmune disease. It manifests in a geneticaly succeptible individual (association with HLA-DQ2, HLS-DQ8) after a variable time of the consumation of gluten containing cereals. Imunopathogenesis of celaic sprue has not been fully discovered. It is supposed that gliadin peptides (split products of gluten) after presentation to HLA- DQ2 and HLA-DQ8 possitive cells of predisposed individuals trigger in the mucosa of the small bowel an exaggerated reaction (T cell mediated immune response). In the same time highly specific autoimmune antibodies are produced (antibodies against tissue transglutaminase). Final result of reaction to gluten is a damage to small bowel mucosa with variable degree of atrophy and inflammatory changes. Clinical picture of celiac sprue is variable. Typical picture of malabsorption with diarrhea and steatorhea, abdominal distension, anemia, weight loss and slowing of somatic and psychologic development are characteristic mainly for pediatric patients. In adults we observe in patients with celiac sprue frequently minimal gastrointestinal symptomps with dyspepsy or fatigue syndrom. Extraintestinal manifestation prevails with sideropenic anemia and exaggerated osteoporosis. In routine clinical practice a large proportion of patietns with celiac sprue remains undiagnosed and the disease is considered to be uncommon. A necessity for succesful diagnosis of celiac sprue are informed primary care physicians (general practitionars and specialists with an exception of gastroenterologists) who can make use of available methods of targeted screening of early diagnosis of this disease.

Keywords: celiac disease, gluten, serologic screening, diagnosis of celiac sprue, gluten free diet

Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Prokopová L. Celiac disease - what shoUld an ambulant internist know. Interní Med. 2008;10(5):233-239.
Download citation

References

  1. Ackerman Z, Eliakim R, Skalnikowica R, Rachmilewitz D. Role of small bowell biopsy in the endoscopic evaluation of adults with iron deficiancy anemia. Am J Gastroenterol 1996. 91: 2099.
  2. Bai J, Zeballos E, Fried M, et al. World Gastroenterology Organisation Practice Guidelines: Celiac disease. www.worldgastroenterology.org.
  3. Booth CC. History of Coeliac Disease. BMJ. 1989; 298: 527. Go to original source...
  4. Bureš J, Reichert S, et al. Vyšetření tenkého střeva a enteroskopický atlas. Kapitola 11: Celiakie. Grada Publishing, Praha 2001: 211-236.
  5. Dahele A, Kingstone K, et al. Anti-endomysial antibody negative celiac disease: does additional serological testing help? Dig. Dis. Sci. 2001; 46 (1): 214-221. Go to original source... Go to PubMed...
  6. Ferguson A, Arranz E, O´Mahoney S. Clinical and pathological spectrum of coeliac disease - active, silent, latent, potencial. Gut 1993; 34: 150. Go to original source... Go to PubMed...
  7. Frič P. Malabsorpční syndrom. SZN, Praha, 1969; 95-99, 182-199.
  8. Grecol L, Corazza G, Babron MC, et al. Genome search in coeliac disease. Am J Hum Genet. 1998; 62: 669. Go to original source... Go to PubMed...
  9. Kocna P, Bezdíčková D, Tučková L, et al. Sérologická diagnostika celiakie-nový marker tkáňová transglutamináza. Čes.-Slov. Gastroenterol. 1999; 53 (Suppl.): 70-71.
  10. Kotalová R, Vraná M, Dobrovolná M, Nevoral J, Landová M. HLA-DRB1/DQA1/DQB1 alely a haplotypy českých dětí s celiakální sprue. Čas. Lék. čes. 2002; 141/16: 518-522.
  11. Krejsek J, Kopecký O. Céliakální sprue. Klinická imunologie. Nucleus HK, 2004: 831-838.
  12. Lokhi S, Mustalahti K, et al. Increasing prevalence of coeliac disease over time. Alim Pharmacol Therap. Nov. 2007; 26 (9): 1217-1225. Go to original source... Go to PubMed...
  13. Maki M, Collin P. Coeliac disease. Lancet 1997; 349: 1755. Go to original source... Go to PubMed...
  14. Marsh MN. Crowe PT. Morphology of the mucosal intestinal lesion in gluten senzitivity. Baillieres Clin Gastroenterol 1995; 9: 273. Go to original source... Go to PubMed...
  15. McLoughlin R, Sebastian SS, et al. Coeliac disease in Europe. Alim Pharmacol Therap. 2003; 18 (3): 45-48. Go to original source... Go to PubMed...
  16. Mearien ML, Ivarsson A, Dickey W. Coeliac disease: is it time for mass screening? Best. Pract. Res. Clin. Gastroenterol. 2005; 19: 441-452. Go to original source... Go to PubMed...
  17. Nevoral J, Kotalová R. Celiakální sprue. Postgraduální medicína 2002; 4: 14-21.
  18. Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br. J. Dermatol. 1997; 136: 315. Go to original source... Go to PubMed...
  19. Rolny P, Sigurjonsottir HA, Remotti H, et al. Role of immunosupressive therapy in refractory sprue like disease. Am J Gastroenterol 1999; 94: 219. Go to original source... Go to PubMed...
  20. Rostom A, Murray JA, Kagnoff MF. AGA Institute Technical Review on the Diagnosis and Management of Celiac Disease. Gastroenterology Dec. 2006; 131 (6): 1877-1980, 1981-2002. Go to original source... Go to PubMed...
  21. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234. Go to original source... Go to PubMed...
  22. Vašíček M, Frič P, Zavoral M. Push enteroskopie-zkušenosti prvního roku. Endoskopie 2002; 11: 27-33.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.